1. Início
  2. Faculdade de Medicina - FM
  3. Departamento de Moléstias Infecciosas e Parasitárias - FM/MIP
  4. Artigos e Materiais de Revistas Científicas - FM/MIP
Please use this identifier to cite or link to this item: https://observatorio.fm.usp.br/handle/OPI/720
Full metadata record
DC FieldValueLanguage
dc.contributorSistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP-
dc.contributor.authorSILVA FILHO, Luiz Vicente Ribeiro Ferreira da-
dc.contributor.authorZERBINATI, Rodrigo Melim-
dc.contributor.authorTATENO, Adriana Fumie-
dc.contributor.authorBOAS, Lucy Vilas-
dc.contributor.authorALMEIDA, Marina Buarque de-
dc.contributor.authorLEVI, Jose Eduardo-
dc.contributor.authorDREXLER, Jan Felix-
dc.contributor.authorDROSTEN, Christian-
dc.contributor.authorPANNUTI, Claudio Sergio-
dc.date.accessioned2013-07-30T15:07:45Z-
dc.date.available2013-07-30T15:07:45Z-
dc.date.issued2012-
dc.identifier.citationJOURNAL OF INFECTIOUS DISEASES, v.206, n.3, p.384-388, 2012-
dc.identifier.issn0022-1899-
dc.identifier.urihttps://observatorio.fm.usp.br/handle/OPI/720-
dc.description.abstractWe investigated the clinical impact of human coronaviruses (HCoV) OC43, 229E, HKU1 and NL63 in pediatric patients with cystic fibrosis (CF) during routine and exacerbation visits. A total of 408 nasopharyngeal aspirate samples were obtained from 103 patients over a 1-year period. Samples positive for HCoV were submitted for nucleotide sequencing to determine the species. Nineteen samples (4.65%) were positive for HCoV, of which 8 were positive for NL63, 6 for OC43, 4 for HKU1, and 1 for 229E. Identification of HCoV was not associated with an increased rate of respiratory exacerbations, but NL63-positive patients had higher exacerbation rates than patients who were positive for other HCoV species.-
dc.description.sponsorshipFundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [05/01625-8]-
dc.language.isoeng-
dc.publisherOXFORD UNIV PRESS INC-
dc.relation.ispartofJournal of Infectious Diseases-
dc.rightsrestrictedAccess-
dc.subject.otherrespiratory-tract disease-
dc.subject.otheridentification-
dc.subject.otherpneumonia-
dc.subject.otherhku1-
dc.subject.othernl63-
dc.titleThe Differential Clinical Impact of Human Coronavirus Species in Children With Cystic Fibrosis-
dc.typearticle-
dc.rights.holderCopyright OXFORD UNIV PRESS INC-
dc.identifier.doi10.1093/infdis/jis274-
dc.identifier.pmid22459737-
dc.subject.wosImmunology-
dc.subject.wosInfectious Diseases-
dc.subject.wosMicrobiology-
dc.type.categoryoriginal article-
dc.type.versionpublishedVersion-
hcfmusp.author.externalDREXLER, Jan Felix:Univ Bonn, Med Ctr, Inst Virol, Bonn, Germany-
hcfmusp.author.externalDROSTEN, Christian:Univ Bonn, Med Ctr, Inst Virol, Bonn, Germany-
hcfmusp.description.beginpage384-
hcfmusp.description.endpage388-
hcfmusp.description.issue3-
hcfmusp.description.volume206-
hcfmusp.origemWOS-
hcfmusp.origem.idWOS:000306369100011-
hcfmusp.origem.id2-s2.0-84863913456-
hcfmusp.publisher.cityCARY-
hcfmusp.publisher.countryUSA-
hcfmusp.relation.referenceArden KE, 2005, J MED VIROL, V75, P455, DOI 10.1002/jmv.20288-
hcfmusp.relation.referenceArkwright PD, 2003, AM J RESP CRIT CARE, V167, P384, DOI 10.1164/rccm.200204-364OC-
hcfmusp.relation.referencede Almeida MB, 2010, EMERG INFECT DIS, V16, P996, DOI 10.3201/eid1606.100063-
hcfmusp.relation.referenceDrosten C, 2003, NEW ENGL J MED, V348, P1967, DOI 10.1056/NEJMoa030747-
hcfmusp.relation.referenceFielding BC, 2011, FUTURE MICROBIOL, V6, P153, DOI [10.2217/fmb.10.166, 10.2217/FMB.10.166]-
hcfmusp.relation.referenceGaunt ER, 2010, J CLIN MICROBIOL, V48, P2940, DOI 10.1128/JCM.00636-10-
hcfmusp.relation.referenceKupfer B, 2007, EUR J MED RES, V12, P134-
hcfmusp.relation.referenceMCINTOSH K, 1974, J INFECT DIS, V130, P502-
hcfmusp.relation.referenceOlesen HV, 2006, PEDIATR PULM, V41, P1197, DOI 10.1002/ppul.20517-
hcfmusp.relation.referenceRatjen F, 2003, LANCET, V361, P681, DOI 10.1016/S0140-6736(03)12567-6-
hcfmusp.relation.referenceTalbot HK, 2009, PEDIATR INFECT DIS J, V28, P682, DOI 10.1097/INF.0b013e31819d0d27-
hcfmusp.relation.referencevan der Hoek L, 2004, NAT MED, V10, P368, DOI 10.1038/nm1024-
hcfmusp.relation.referenceWat D, 2008, J CYST FIBROS, V7, P320, DOI 10.1016/j.jcf.2007.12.002-
hcfmusp.relation.referenceWevers BA, 2010, FUTURE VIROL, V5, P145, DOI 10.2217/FVL.10.4-
hcfmusp.relation.referenceWoo PCY, 2005, J VIROL, V79, P884, DOI 10.1128/JVI.79.2.884-895.2005-
dc.description.indexMEDLINE-
hcfmusp.remissive.sponsorshipFAPESP-
hcfmusp.lim.ref2012-
hcfmusp.citation.scopus27-
hcfmusp.scopus.lastupdate2024-04-12-
Appears in Collections:

Artigos e Materiais de Revistas Científicas - FM/MIP
Departamento de Moléstias Infecciosas e Parasitárias - FM/MIP

Artigos e Materiais de Revistas Científicas - HC/ICHC
Instituto Central - HC/ICHC

Artigos e Materiais de Revistas Científicas - HC/ICr
Instituto da Criança - HC/ICr

Artigos e Materiais de Revistas Científicas - HC/InCor
Instituto do Coração - HC/InCor

Artigos e Materiais de Revistas Científicas - LIM/36
LIM/36 - Laboratório de Pediatria Clínica

Artigos e Materiais de Revistas Científicas - LIM/52
LIM/52 - Laboratório de Virologia


Files in This Item:
File Description SizeFormat 
art_SILVA FILHO_The_Differential_Clinical_Impact_of_Human_Coronavirus_Species_2012.PDF
  Restricted Access		publishedVersion (English)148.69 kBAdobe PDFView/Open Request a copy
Show simple item record

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.